DiagnaMed Holdings Corp. (TSE:DMED) has released an update.
DiagnaMed Holdings Corp. has announced a significant development in brain health technology with the clinical validation of its BRAIN AGE® Brain Health AI Platform, a tool that uses AI to estimate brain age and provide health scores based on EEG brain scans. This breakthrough, supported by peer-reviewed research, could revolutionize early screening for brain diseases and track the effectiveness of interventions. The platform, which is aimed at a broad market including healthy individuals and those with neurological conditions, offers a cost-effective solution for regular brain health monitoring.
For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.
